FIELD: medical engineering. SUBSTANCE: method involves combining at least two ingredients taken from animal tissues and/or being of human origin. Their denaturation is carried out mainly with carbamide applied to obtain homogeneous phase. The phase is divided into two parts. One of them is used for separating the given ingredient that is added to the rest portion next to it. Renaturation is carried out. EFFECT: improved properties; wider activity range. 5 cl
| Title | Year | Author | Number |
|---|---|---|---|
| BIOLOGICALLY ACTIVE COMPLEX FOR ORGANOGENESIS | 1990 |
|
RU2093191C1 |
| ENDOPROSTHESIS OF LONG-TERM STABILITY | 2000 |
|
RU2260446C2 |
| PHARMACEUTICAL COMPOSITIONS AIMED AT Erb-B1 RECEPTORS | 2003 |
|
RU2354402C2 |
| COMPOSITIONS AND METHODS FOR REGULATION OF VESSELS DEVELOPMENT | 2005 |
|
RU2365382C2 |
| IMPLANT FOR REPAIRING VERTEBRAE AND TUBULAR BONES | 2000 |
|
RU2261116C2 |
| BIOACTIVE COMPLEX FOR ORGANOGENESIS | 2003 |
|
RU2254146C2 |
| GENETICALLY MODIFIED CELLS AND THEIR APPLICATION FOR PROPHYLAXIS OR TREATMENT OF SICKNESSES | 1998 |
|
RU2205029C2 |
| METHOD FOR PRODUCING LACTOFERRIN, LACTOFERRIN-CONTAINING FRACTION AND USING IT | 2010 |
|
RU2579661C2 |
| ACELLULAR TRANSPLANT | 2006 |
|
RU2404820C2 |
| RECOMBINANT LECTIN FROM WHITE MISTLETOE (RML) | 1996 |
|
RU2241750C2 |
